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Abstract 
Thioflavin T (ThT) dye fluorescence is used regularly to quantify the formation and inhibition of amyloid 
fibrils in the presence of anti-amyloidogenic compounds such as polyphenols. However, in this study, it 
was shown, using three polyphenolics (curcumin, quercetin and resveratrol), that ThT fluorescence should 
be used with caution in the presence of such exogenous compounds. The strong absorptive and 
fluorescent properties of quercetin and curcumin were found to significantly bias the ThT fluorescence 
readings in both in situ real-time ThT assays and single time-point dilution ThT-type assays. The presence 
of curcumin at concentrations as low as 0.01 and 1 uM was sufficient to interfere with the ThT 
fluorescence associated with fibrillar amyloid-b(1-42) (0.5 uM) and fibrillar reduced and 
carboxymethylated kappa-casein (50 lm), respectively. The ThT fluorescence associated with fibrillar 
amyloid-b(1-42) was also biased using higher concentrations of resveratrol, a polyphenol that is not 
spectroscopically active at the wavelengths of ThT fluorescence, implying that there can be direct 
interactions between ThT and the exogenous compound and/or competitive binding with ThT for the 
fibrils. Thus, in all cases where ThT is used in the presence of an exogenous compound, biases for 
amyloid-associated ThT fluorescence should be tested, regardless of whether the additive is 
spectroscopically active. Simple methods to conduct these tests were described. The Congo red spectral 
shift assay is demonstrated as a more viable spectrophotometric alternative to ThT, but allied methods, 
such as transmission electron microscopy, should also be used to assess fibril formation independently 
of dye-based assays. 
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Thioflavin T (ThT) dye fluorescence is used regularly to quantify the for-
mation and inhibition of amyloid fibrils in the presence of anti-amyloido-
genic compounds such as polyphenols. However, in this study, it was
shown, using three polyphenolics (curcumin, quercetin and resveratrol),
that ThT fluorescence should be used with caution in the presence of such
exogenous compounds. The strong absorptive and fluorescent properties of
quercetin and curcumin were found to significantly bias the ThT fluores-
cence readings in both in situ real-time ThT assays and single time-point
dilution ThT-type assays. The presence of curcumin at concentrations as
low as 0.01 and 1 lm was sufficient to interfere with the ThT fluorescence
associated with fibrillar amyloid-b(1-42) (0.5 lm) and fibrillar reduced and
carboxymethylated j-casein (50 lm), respectively. The ThT fluorescence
associated with fibrillar amyloid-b(1-42) was also biased using higher con-
centrations of resveratrol, a polyphenol that is not spectroscopically active
at the wavelengths of ThT fluorescence, implying that there can be direct
interactions between ThT and the exogenous compound and ⁄or competi-
tive binding with ThT for the fibrils. Thus, in all cases where ThT is used
in the presence of an exogenous compound, biases for amyloid-associated
ThT fluorescence should be tested, regardless of whether the additive is
spectroscopically active. Simple methods to conduct these tests were
described. The Congo red spectral shift assay is demonstrated as a more
viable spectrophotometric alternative to ThT, but allied methods, such as
transmission electron microscopy, should also be used to assess fibril
formation independently of dye-based assays.
Structured digital abstract
l MINT-7259867: RCMj-CN (uniprotkb:P02668) and RCMj-CN (uniprotkb:P02668) bind
(MI:0407) by electron microscopy (MI:0040)
l MINT-7258930: RCMj-CN (uniprotkb:P02668) and RCMj-CN (uniprotkb:P02668) bind
(MI:0407) by fluorescence technologies (MI:0051)
l MINT-7259878: Amyloid beta (uniprotkb:P05067) and Amyloid beta (uniprotkb:P05067) bind
(MI:0407) by fluorescence technologies (MI:0051)
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Introduction
Over 40 debilitating and incurable human diseases are
associated with the failure of a specific peptide or pro-
tein to adopt, or remain in, its native functional state
[1]. These conditions are referred to as protein misfold-
ing diseases and include pathologies as diverse as Alz-
heimer’s disease, Parkinson’s disease, cataracts and
type-II diabetes [1,2]. The majority of misfolding dis-
eases are associated with amyloidosis, a pathological
state involving the self-aggregation of specific proteins
(or protein fragments) into cytotoxic filamentous
deposits known as amyloid fibrils, which adopt a char-
acteristic cross-b-sheet structure [1–3].
In this field, extrinsic fluorescence of the benzothiaz-
ole dye, thioflavin T (ThT), is widely used for the iden-
tification and quantification of amyloid fibrils in vitro,
and has become the premier technique used to monitor
fibrillation kinetics in real-time [4,5]. When ThT is
added to samples containing b-sheet-rich deposits, such
as the cross-b-sheet quaternary structure of amyloid
fibrils, it fluoresces strongly with excitation and emis-
sion maxima at approximately 440 and 490 nm,
respectively [6,7]. Free ThT in an aqueous environ-
ment, however, shows only weak fluorescence, with
lower (blue-shifted) excitation and emission maxima at
350 and 440 nm, respectively [6]. Although the mecha-
nism of interaction between ThT and amyloid fibrils
remains poorly understood, the most widely accepted
theory involves the intercalation of ThT molecules
within grooves between solvent-exposed side chains of
the amyloid fibril that run parallel to the fibril axis
[5,8,9]. Binding within the channels is thought to pro-
vide rigidity and to prevent the formation of a
less-radiative twisted internal charge-transfer state of
the ThT molecule in the excited singlet state, which is
normally accompanied by growth of the torsion angle
between the benzthiazole and benzene ring from 37 to
90 [10]. As there is a stoichiometric and saturable
interaction between ThT and amyloid fibrils, fluores-
cence from the amyloid–ThT complex provides accu-
rate quantification of amyloid fibril formation as a
function of amyloid fibril length and number [4]. In
the so-called ThT fluorescence assay, ThT is simply
added to samples containing fibril structures at a con-
centration in excess of the number of potential ThT–
fibril binding sites, and steady-state ThT fluorescence
emission is monitored at  490 nm (excitation at
 440 nm). There are two common variations to this
assay: the in situ real-time ThT assay, whereby fibril
formation is carried out in the presence of ThT, thus
providing a means to monitor fibrillation kinetics in
real-time; and a single time-point dilution ThT assay,
in which samples of a fibril-forming polypeptide are
diluted into buffered solutions of ThT, providing sim-
pler single time-point readings.
Over the past 5 years, a wide range of compounds,
known as anti-amyloids (or anti-aggregates), have been
reported to prevent amyloid fibril formation, reverse
fibrillation and to protect against amyloid fibril-
induced cytotoxicity [11–15]. One class of compounds
that has received considerable attention is the natural
polyphenols, which comprise over 8000 plant-derived
molecules found in high concentrations in wine, tea,
spices and berries [16,17]. For instance, recent studies
of the most abundant polyphenolic extract from green
tea, (-)-epigallocatechin-3-gallate, show that it effi-
ciently suppresses fibril formation by a-synuclein and
amyloid-b, the amyloidogenic proteins involved in Par-
kinson’s and Alzheimer’s diseases respectively, and
redirects their aggregation down an off-pathway yield-
ing nontoxic unstructured oligomers [18]. We have
recently reported that (-)-epigallocatechin-3-gallate also
inhibits fibril formation by the milk protein, reduced
and carboxymethylated j-casein (RCMj-CN), through
a distinct mechanism whereby the protein is
constrained in its native-like state [19]. The phenolic
aromatic rings of polyphenols are often connected via
conjugated systems, resulting in strong p fi p* elec-
tronic transitions and making them chromophoric and
even intrinsically fluorescent [20–22]. This spectro-
scopic activity commonly occurs at the principal wave-
lengths of ThT fluorescence, which in theory makes
the ThT fluorescence assay unsuitable for studies
where the fibril-forming polypeptide is mixed with such
compounds. However, when reviewing the literature
on polyphenols, it is found that despite the caution of
such practices by LeVine [23], the ThT fluorescence
assay is employed widely in the presence of such
polyphenols (i.e. as a means to assess their anti-amy-
loid activity) [24–34]. In fact, it is of concern that in
many studies the ThT technique is used as the sole
measure of the in vitro anti-aggregation efficacy of
these compounds [24,27,30,32–34].
In this study, we illustrated the potential unsuitabil-
ity of ThT as a probe for amyloid fibril formation in
the presence of exogenous additives by examining the
effect of three polyphenols (curcumin, quercetin and
resveratrol) on the fluorescence emission of ThT in
both in situ real-time ThT assays and single time-point
dilution ThT-type assays. We utilized the generic
model amyloid fibril-forming protein with which we
have considerable experience, namely RCMj-CN,
which is easily prepared and is highly amyloidogenic
S. A. Hudson et al. Exogenous compounds can bias thioflavin T assays
FEBS Journal 276 (2009) 5960–5972 ª 2009 The Authors Journal compilation ª 2009 FEBS 5961
under conditions of physiological temperature and pH,
and does not require denaturants [35,36]. As theorized,
it is found that the presence of the polyphenols signifi-
cantly biases the RCMj-CN fibril-associated ThT fluo-
rescence, and these findings are corroborated using
fibrillar amyloid-b(1-42) peptide [37]. The use of the
absorptive dye, Congo red (CR), is demonstrated as a
viable alternative to ThT, but it is also stressed that
other methods, such as transmission electron micros-
copy (TEM) should be used to assess fibril formation
independently of dyes.
Results
The coupled effect of polyphenols on amyloid
fibril formation and on the in situ real-time ThT
assay
In order to explore the coupled effects of the selected
polyphenolics, curcumin, quercetin and resveratrol
(Fig. 1A), on amyloid fibril formation and on in situ
real-time ThT fluorescence, a solution of native
RCMj-CN (50 lm) containing ThT (10 lm) was incu-
bated at 37 C in the presence and absence of the
polyphenols (1–100 lm) and the change in ThT
fluorescence emission was monitored (Fig. 1). As previ-
ously reported, the initial decrease in in situ ThT fluo-
rescence emission during the first 30 min of incubation
is attributable to the samples warming to the incuba-
tion temperature [36]. This was confirmed by monitor-
ing the temperature-dependence of ThT fluorescence
induced with fibrillar RCMj-CN (Fig. S1). The ThT
fluorescence of RCMj-CN incubated alone increased
rapidly after the equilibration period and reached a
plateau after 800–1000 min, which is indicative of
RCMj-CN amyloid fibril formation (0, Fig. 1B–D)
[35,36]. The addition of quercetin led to a concentra-
tion-dependent decrease in the apparent ThT fluores-
cence (Fig. 1B), which on its own suggests the efficient
concentration-dependent inhibition of fibril formation.
Resveratrol, at concentrations up to 100 lm, had little
effect on the ThT fluorescence response up to 400 min,
and only a small concentration-dependent decrease in
fluorescence was observed at later time-points
(Fig. 1C). In stark contrast to the effects of quercetin
and resveratrol, the apparent ThT fluorescence was
found to vary markedly with the concentration of
curcumin (Fig. 1D). At a concentration of 1–10 lm,
curcumin increased the apparent ThT fluorescence,
whereas at 50 and 100 lm, the fluorescence was
A B
C D
Fig. 1. Effect of the polyphenols, quercetin, resveratrol and curcumin, on RCMj-CN amyloid fibril formation and the associated increase in
in situ ThT fluorescence. (A) The structure of ThT and the polyphenols used in this study. (B–D) In situ real-time ThT fluorescence assays of
solutions of fresh native RCMj-CN (50 lM) incubated at 37 C in the presence of quercetin (B), resveratrol (C) and curcumin (D). For each
assay, polyphenol (100 lM) without RCMj-CN was also monitored (control). Values shown are the mean readings from three individual
experiments, and the standard error for each data point is within 4% (not visible).
Exogenous compounds can bias thioflavin T assays S. A. Hudson et al.
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decreased, implying an inhibition of amyloidogenesis.
When the polyphenols were incubated with ThT in the
absence of RCMj-CN, there was no significant change
in ThT fluorescence over the course of the incubation
period, indicating that they do not form amyloid fibrils
themselves, nor are they likely to interact directly with
free, solvated ThT (control, Fig. 1B–D).
Curcumin, quercetin and resveratrol affect
RCMj-CN fibril morphology with similar efficacy
The morphological effects of the polyphenols on
RCMj-CN aggregation were assessed simultaneously
by TEM (Fig. 2). In agreement with our previous stud-
ies [35,36], TEM micrographs of RCMj-CN alone,
taken before fibril formation, indicated that RCMj-
CN exists initially as globular micelle-like species with
diameters of  30 nm (Fig. 2A). At plateaus of the
in situ ThT fluorescence curves (i.e. post-incubation),
most prefibrillar entities have been incorporated into
mature amyloid fibrils (Fig. 2B). In contrast to the
previous in situ real-time ThT fluorescence experi-
ments, all polyphenols (at the same concentration)
appeared to affect RCMj-CN aggregation similarly,
giving a combination of stunted fibrillar and prefibril-
lar assemblies when RCMj-CN was incubated in their
presence (Fig. 2C–E). To investigate this discrepancy
between the TEM and real-time ThT assays, in rela-
tion to the possibility that the polyphenols bias the
apparent ThT fluorescence, the spectroscopic proper-
ties of ThT and the polyphenols in the presence of
fibrils were examined more closely.
The spectroscopic activity of quercetin and
curcumin bias ThT fluorescence
To explore the spectroscopic relationships between
ThT and the polyphenols, UV-visible absorption spec-
tra (320–650 nm) of curcumin, quercetin and resvera-
trol solutions (100 lm) were recorded (Fig. 3A). The
absorption spectrum of RCMj-CN (50 lm) + ThT
(10 lm), pre-incubated for 20 h to induce the forma-
A B
C D
E
Fig. 2. TEM micrographs of samples from
the in situ ThT fluorescence assays (see
Fig. 1), taken before or after the 1100 min
incubation period to investigate the morpho-
logical effects of quercetin, resveratrol and
curcumin on RCMj-CN aggregation. (A)
Fresh native RCMj-CN (50 lM) before incu-
bation, (B) RCMj-CN alone (50 lM) follow-
ing incubation and (C–E) RCMj-CN (50 lM)
in the presence of polyphenols (100 lM)
after incubation: quercetin (C), resveratrol
(D) and curcumin (E). Bars represent
200 nm.
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tion of fibrils, was also acquired (20 h RCMj-CN and
ThT; Fig. 3A). At these concentrations, the broad
absorption bands of the highly conjugated chromo-
phores of quercetin and curcumin (absorption maxima
at 374 and 426 nm, respectively) completely dominated
the ThT absorption (maxima at approximately
440 nm; i.e. the excitation wavelength for the ThT
fluorescence assay). This implies that when quercetin
and curcumin are present in the real-time ThT assay,
they will cause significant inner filter effects leading to
effective quenching of the ThT fluorescence (i.e. by
absorbing both the light intended to excite ThT and
the ThT fluorescence radiation emitted). By contrast,
resveratrol showed no absorption above 350 nm and
is thus unlikely to influence ThT fluorescence on a
spectroscopic basis (Fig. 3A).
A B C
D E F
G H
Fig. 3. UV-visible absorption, ThT interaction and steady-state fluorescence emission characteristics of curcumin, quercetin and resveratrol.
(A) The absorption spectra (320–650 nm) of curcumin, quercetin and resveratrol solutions (100 lM) are shown. Also shown is the absorption
spectrum of pre-incubated fibrillar RCMj-CN (50 lM) and ThT (10 lM). (B–D) Steady-state ThT fluorescence emission spectra (kex 440 nm,
kem 470–700 nm) of pre-incubated fibrillar RCMj-CN (50 lM) and ThT (10 lM) in the absence of polyphenols (0 lM). Quercetin (B), resveratrol
(C) or curcumin (D) were added at various concentrations (1–100 lM) and the fluorescence spectra were re-acquired immediately. (E)
Steady-state curcumin fluorescence emission spectra (kex 426 nm, kem 450–700 nm) of fresh native RCMj-CN (50 lM) with curcumin
(1–100 lM). The spectrum of curcumin (100 lM) without RCMj-CN is also shown (control). (F–H) Steady-state ThT fluorescence emission spec-
tra (kex 440 nm, kem 470–650 nm) of fibrillar amyloid-b(1-42) (0.5 lM) and ThT (5 lM) in the absence of polyphenols (0 lM). Quercetin (F), resve-
ratrol (G) or curcumin (H) were added at various concentrations (0.01–5 lM) and the fluorescence spectra were re-acquired immediately.
Exogenous compounds can bias thioflavin T assays S. A. Hudson et al.
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Next, the direct effect of the polyphenols on the
ThT fluorescence emission spectrum (kex 440 nm, kem
470–700 nm) was examined by adding curcumin, quer-
cetin or resveratrol (1–100 lm) to pre-incubated fibril-
lar RCMj-CN (50 lm) and ThT (10 lm) (Fig. 3B–D).
The fluorescence spectra were acquired immediately
after the addition of the polyphenol. As hypothesized,
the addition of quercetin at high concentrations
(100 lm) significantly decreased the ThT fluorescence
yield (37% at 490 nm) (Fig. 3B) and the presence of
resveratrol did not alter the ThT fluorescence spectra
from fibrillar RCMj-CN alone (Fig. 3C). Based on
these data, the real-time ThT fluorescence assay for
RCMj-CN treated with resveratrol (Fig. 1C) appeared
not to be influenced by resveratrol, therefore indicating
that resveratrol has little anti-aggregation activity
against RCMj-CN. The concentration-dependent inhi-
bition effect observed for quercetin (Fig. 1B) is, how-
ever, clearly affected by quenching of the ThT
fluorescence and cannot be attributed solely to an
inhibitory effect on fibril formation (compare Fig. 1B
with Fig. 2C). Curcumin added at low concentrations
(1, 5 and 10 lm) enhanced the apparent emission of
ThT fluorescence, but at higher concentrations
(100 lm) the fluorescence yield was substantially
decreased (Fig. 3D). Furthermore, the spectrum shape
was altered, with the maximum emission wavelength
increasing (red-shifted) at higher concentrations of
curcumin.
These results for curcumin may be explained by
recent studies showing that although curcumin is
weakly fluorescent in water, it becomes highly fluores-
cent in aqueous solutions containing detergents and as
a result of binding to hydrophobic regions on proteins
such as human serum albumin or bovine serum albu-
min [22,38,39]. This implies that curcumin will become
fluorescent in the presence of amyloid fibril-forming
proteins, such as RCMj-CN, which inherently have
exposed hydrophobic regions that mediate the process
of aggregation [2,36]. Hence, intrinsic curcumin fluo-
rescence may contribute to the apparent real-time ThT
fluorescence (Fig. 1D) and this may help to explain the
different ThT-interfering effects observed for curcumin
and quercetin (compare Fig. 3B with Fig. 3D). To
verify this, the steady-state curcumin fluorescence
emission spectra (kex 426 nm, kem 450–700 nm) of
freshly prepared native RCMj-CN (50 lm) with curcu-
min (1–100 lm) were acquired (Fig. 3E). The control
curcumin solution (100 lm) showed weak fluorescence.
As postulated, for all concentrations of curcumin in
the presence of RCMj-CN (50 lm), the fluorescence
yield of curcumin was substantially enhanced. The
emission intensity was maximal up to a saturation
concentration of curcumin of between 10 and 50 lm.
At higher concentrations, the additional solvated and
nonfluorescent curcumin is likely to re-absorb the fluo-
rescence radiation, leading to self-quenching [40]. The
curcumin fluorescence spectra are also red-shifted with
increasing concentrations, which suggests increased sol-
vent relaxation [40]. Significantly, the wavelength range
of curcumin fluorescence emission overlaps signifi-
cantly with the emission spectrum of ThT fluorescence
(compare Fig. 3B–D with Fig. 3E). Hence, the apparent
ThT fluorescence spectrum in the presence of curcumin
would be influenced by a combination of both the
absorptive (subtractive) and fluorescent (additive)
properties of free curcumin and solvent-shielded curcu-
min, respectively (depending on the concentration of
curcumin) (compare Fig. 3A with Fig. 3E). These spec-
tral properties provide an explanation for the complex
profiles of fluorescence observed for the in situ real-
time ThT assay for RCMj-CN aggregation conducted
in the presence of curcumin (Fig. 1D).
Dilution ThT assay techniques do not overcome
the spectroscopic biases of polyphenols and
reveal the occurrence of nonspectral interference
effects
In the previous sections it is demonstrated that in situ
real-time ThT fluorescence assays are heavily biased by
the presence of the polyphenols, quercetin and curcu-
min. These real-time ThT fluorescence assays are per-
formed typically with relatively high concentrations of
fibril-forming polypeptide to necessitate amyloidogene-
sis. However, the effect of any exogenous compound
on ThT fluorescence is, of course, relative to its con-
centration and the magnitude of ThT fluorescence
emission (a function of ThT concentration, concentra-
tion and type of amyloidogenic protein under study,
temperature and the buffer system employed) [23,41].
Exploiting this fact, some studies suggest that the
ThT-interfering effects of additives to the ThT fluores-
cence assay (particularly polyphenols), can be over-
come by performing single time-point dilution ThT
assays where protein samples are diluted into a ThT
solution (i.e. thereby diluting out the effects of the
added chromophores while in theory maintaining a
sufficiently high intensity of fibril-induced ThT
fluorescence for detection) [25,26,28,29].
To investigate these claims and to substantiate the
previous findings made using RCMj-CN, dilution ThT
assays were performed using the standard dilute con-
centration of pre-incubated fibrillar amyloid-b(1-42)
(0.5 lm). Curcumin, quercetin or resveratrol was then
added at concentration ranges that are typical of those
S. A. Hudson et al. Exogenous compounds can bias thioflavin T assays
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used in previous studies [24–34] (Fig. 3FH). As seen
with RCMj-CN, the immediate addition of quercetin
to fibrillar amyloid-b(1-42) led to a dramatic concen-
tration-dependent decrease in ThT fluorescence (i.e. a
42 and 60 % decrease in fluorescence intensity was
observed at 490 nm upon the addition of 1 and 5 lm
quercetin, respectively) (Fig. 3F, compare with Fig. 3B).
The addition of resveratrol, by contrast, had a
markedly different effect on the ThT fluorescence
induced with amyloid-b(1-42) in comparison to
RCMj-CN. The ThT fluorescence yield was reduced
significantly at the higher concentrations of resveratrol,
despite resveratrol being spectroscopically inactive in
the ThT fluorescence range (Fig. 3A). For example,
there was a 39 % decrease in ThT fluorescence inten-
sity at 490 nm in the presence of 5 lm resveratrol
(Fig. 3G, compare with Fig. 3C). These findings clearly
indicate that nonspectroscopic-based interferences pri-
marily account for this bias in the ThT fluorescence.
Moreover, because there is insufficient time for resve-
ratrol to disrupt the highly stable fibril complexes after
its initial addition, the effect is most likely to involve
direct interactions between resveratrol and ThT, or
competitive binding between resveratrol and ThT for
sites along the fibril structure. The ThT fluorescence
spectra of the samples with resveratrol were also moni-
tored continuously over a period of 48 h, but there
was no significant decrease in intensity after the large
initial decrease (data not shown). It therefore appears
that an equilibrium involving these nonspectral interac-
tions is rapidly established. This nonspectroscopic
interference may not be observed in the same assay
with identical molar ratios of resveratrol to fibrillar
RCMj-CN (Fig. 3C) as a result of the inherent varia-
tions in the make-up of the amyloid-b(1-42) and
RCMj-CN fibrils, or simply because of the presence
of a greater concentration of fibrillar RCMj-CN for
ThT. Alternatively, assuming that a competitive amy-
loid–resveratrol interaction is involved in both cases,
this may suggest that resveratrol has a greater affinity
for amyloid-b(1-42) and displaces amyloid-bound ThT.
Curcumin exhibits a clear concentration-dependent
inhibitory effect on the ThT fluorescence yield in the
presence of preformed amyloid-b(1-42) fibrils, with no
significant change observed in the shape of the emis-
sion spectrum (Fig. 3H). This effect was also markedly
different to that observed with RCMj-CN (Fig. 3D),
implying that, like quercetin, the spectral effects of
curcumin are primarily absorptive, such that, at the
diluted concentrations, curcumin is not adequately sol-
vent-shielded by the hydrophobic peptide to become
fluorescent. Curcumin modulates the ThT fluorescence
to the greatest extent of all the studied polyphenols,
giving dramatic interfering effects at a concentration
as low as 0.01 lm. Therefore, it is evident that even
after diluting fibril samples, the low concentrations of
exogenous additive can still adversely bias the ThT
fluorescence response. Moreover, when comparing
spectroscopic versus possible nonspectroscopic interfer-
ence in the cases of quercetin and curcumin, it is clear
that spectroscopic effects are the prominent contribu-
tor to the interference of ThT fluorescence by these
two polyphenols.
CR dye binding as an alternative to ThT
The CR dye is a less commonly used spectrophotomet-
ric alternative to ThT for easily quantifying amyloid
fibril formation [5,42]. CR is structurally similar to
ThT and is believed to bind to b-sheet-rich structures
in a similar manner [8,43]. Binding induces a charac-
teristic increase in absorption and red shift in the CR
absorption band from 490 to 540 nm [43,44]. Although
CR is known to partially inhibit fibril formation and is
thus unsuitable for an in situ-type assay, its use in sin-
gle time-point experiments (the CR spectral shift assay)
has been well established (i.e. where CR is added to
aliquots of fibril-forming polypeptide and the CR
absorption band is recorded immediately) [42,45,46].
Because the CR spectral shift assay relies on obtaining
absorption spectra at longer wavelengths than used for
the ThT fluorescence assay, it potentially enables the
quantification of amyloid fibrils in the presence of
coloured compounds that interfere with ThT fluores-
cence (or possibly even other types of ThT-interfering
compounds) [7,42].
To investigate this possibility, the CR absorption
spectra (450–600 nm) of solutions of pre-incubated
fibrillar RCMj-CN (50 lm) and CR (20 lm), with and
without added curcumin, quercetin or resveratrol
(100 lm), were recorded (Fig. 4A). The absorption
spectra were acquired immediately after the addition
of the polyphenol. The spectra of CR (20 lm) alone
was also recorded (CR only, Fig. 4A). For all mix-
tures, the absorption shoulder at 540 nm from the CR
control is indicative of CR binding to amyloid fibrils
[43,44]. Importantly, it appears that the polyphenols
only affect the CR spectral shift curve as a result of
their spectroscopic properties, which can be easily
accounted for via subtraction of the absorption spec-
trum of a control solution. For instance, the CR spec-
tra of fibrillar RCMj-CN in the presence and absence
of quercetin or resveratrol are identical, as both quer-
cetin and resveratrol do not absorb significantly over
the range of 450–600 nm (Fig. 3A). However, the
chromophore of curcumin does absorb considerably
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over these wavelengths, but subtraction of the absorp-
tion spectrum of the control solution of curcumin
alone (Fig. 3A) resulted in a spectrum identical to that
of fibrillar RCMj-CN alone [compare 20 h RCMj-
CN with CR and curcumin (corrected), Fig. 4A]. In a
similar assay, performed using native RCMj-CN
(50 lm) instead of fibrillar RCMj-CN (because CR,
like ThT, partially binds native RCMj-CN), no differ-
ence in the absorption spectra were observed in the
presence and absence of the polyphenols after the spec-
tral properties of curcumin alone were taken into
account (data not shown). Therefore, because the stud-
ied polyphenols do not significantly affect CR-binding
or its subsequent absorptive properties, it appears that
the CR assay may permit accurate quantification of
fibril formation in the presence of ThT-interfering
compounds, provided that any inherent absorptive
properties of the additives can be accounted for.
With that in mind, an experiment similar to the ThT
fluorescence assay shown in Figure 1 was performed,
using CR spectral shift (i.e. measurement of the absor-
bance at 540 nm upon the addition of 20 lm CR) to
quantify fibril formation before and after incubation,
and therefore to determine the anti-fibril effect of the
polyphenols. The CR absorbance at 540 nm was
recorded for samples of fresh native RCMj-CN
(50 lm) and RCMj-CN (50 lm) incubated at 37 C
for 20 h in the presence and absence of curcumin,
quercetin or resveratrol at the highest concentration
used previously (100 lm) (Fig. 4B). The absorbance
of RCMj-CN alone increased significantly following
incubation, which is indicative of CR binding to
RCMj-CN fibrils. All three polyphenols appeared to
have similarly poor efficacy to prevent the formation of
b-sheet structures capable of binding to CR. Treatment
with quercetin showed the greatest reduction in CR
absorbance at 540 nm compared with RCMj-CN alone
(14 ± 4%). These findings were consistent with both
the TEM data, which showed that all the polyphenols
studied had a similar effect on RCMj-CN aggregation
(Fig. 2), and the seemingly unbiased real-time ThT
assay for RCMj-CN with resveratrol, which showed a
weak anti-aggregation action (Fig. 1C). Hence, it app-
ears that although curcumin, quercetin and resveratrol
significantly modulate the morphology of RCMj-CN
fibril formation, their presence yields little inhibition of
the formation of b-sheet-rich structures.
Discussion
In this study, it is shown that ThT fluorescence (excita-
tion and emission maxima at approximately 440 and
A B 
Fig. 4. The Congo red (CR) spectral shift assay as an alternative to ThT fluorescence for quantifying amyloid fibril formation in the presence
of curcumin, quercetin and resveratrol. (A) CR absorption spectra (450–600 nm) of pre-incubated fibrillar RCMj-CN (50 lM) and CR (20 lM)
in the absence of polyphenols (20 h RCMj-CN with CR). Curcumin, quercetin or resveratrol (100 lM) were added and the absorption spectra
were re-acquired immediately. The spectrum of CR alone (20 lM) is also shown. The strong spectral contribution from curcumin is clearly
visible below 520 nm. This has been accounted for by subtracting the absorption spectrum of a solution containing curcumin alone (100 lM)
(see Fig. 3A). (B) CR absorbance, at 540 nm, of fresh native RCMj-CN (50 lM) or RCMj-CN (50 lM), which was incubated at 37 C for 20 h
in the presence and absence of quercetin, resveratrol or curcumin (100 lM). All samples have CR (20 lM) added immediately before reading
the absorbance. For samples with curcumin, the absorbance readings were corrected for the contribution from the curcumin chromophore
by subtracting the absorbance at 540 nm of a solution of curcumin alone (100 lM) (see Fig. 3A). Values represent mean ± SEM (n = 6); NS,
not significantly different; *P < 0.05 and ***P < 0.001 versus RCMj-CN pre-incubated at 37 C for 20 h alone (one-way ANOVA, Dunnett’s
post hoc test).
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490 nm, respectively) should be used with caution
when quantifying amyloid fibril formation in the pres-
ence of exogenous additives such as polyphenols. By
employing both single time-point dilution ThT assays
and in situ real-time ThT assays in the presence of
standard assay concentrations of curcumin, quercetin
and resveratrol, we demonstrated that such com-
pounds can significantly bias fibril-associated ThT
fluorescence.
Quercetin was strongly absorptive in the spectral
region of ThT fluorescence (Fig. 3A) and at higher
concentrations (relative to the concentration of fibrils)
led to severe inner filter effects and concentration-
dependent quenching of the ThT fluorescence intensity
(Fig. 1B, 3B and 3F). Free solvated curcumin was also
highly absorptive in the spectral range of ThT
(Fig. 3A). In addition, whilst curcumin is only weakly
fluorescent in water, it becomes highly fluorescent in
hydrophobic environments, such as when it interacts
with an amyloidogenic protein (Fig. 3E) [22,39]. Based
on studies of curcumin and other hydrophobic pro-
teins, including human serum albumin and bovine
serum albumin, it is believed that such hydrophobic
species act as vehicles in which curcumin is carried and
protected from exposure to solvent [22,39]. These fluo-
rescent properties of curcumin also overlapped the
wavelengths of ThT fluorescence (Fig. 3E). Hence, the
in situ real-time ThT fluorescence assay was affected
by both the strong absorptive and fluorescent proper-
ties of free curcumin and solvent-shielded curcumin,
respectively (depending on its concentration, compare
Fig. 1D with Fig. 3D). However, in the absence of suf-
ficient amyloid fibrils to elicit curcumin fluorescence,
as was the case in the single-point dilution ThT assay,
the absorptive properties of curcumin dominate and
a concentration-dependent quenching effect was
observed (Fig. 3H). Importantly, in the presence of
fibrillar amyloid-b(1-42) (0.5 lm) and fibrillar reduced
and carboxymethylated j-casein (RCMj-CN) (50 lm)
the biasing effects of curcumin were found to extend
to curcumin concentrations as low as 0.01 and 1 lm,
respectively (Fig. 3D,H).
Resveratrol had no significant absorption within the
spectral ranges of ThT fluorescence (Fig. 3A). The
real-time ThT assay for RCMj-CN treated with resve-
ratrol thus appears to be able to quantify fibril forma-
tion, indicating that resveratrol does not prevent
RCMj-CN aggregation efficiently (Fig. 1C and 3C).
However, in the dilution ThT assay, resveratrol at
higher concentrations (5 lm) significantly decreased
the ThT fluorescence induced by fibrillar amyloid-b
(1-42) (Fig. 3G), suggesting that nonspectroscopic
effects of polyphenols can also play a role in biasing
ThT fluorescence. As this interfering effect was
observed immediately after the addition of resveratrol
to the ThT-fibrillar amyloid-b(1-42) complex, and its
magnitude did not change over time, it is unlikely to
be attributable to fibril dissolution. Rather, the results
suggest that either resveratrol interacts directly with
ThT (in the amyloid-bound or unbound state),
decreasing its fluorescence intensity, or resveratrol
competitively binds with ThT for b-sheet-rich sites
along the length of fibrils and is able to displace ThT
from these sites. This finding is perhaps not unex-
pected in light of the similar aromatic structures of
ThT and polyphenols (Fig. 1A).
The nonspectral biases identified using resveratrol
are an important finding of this work because they
indicate that an exogenous compound added in ThT
fluorescence assays does not necessarily have to be
spectroscopically active to bias the ThT fluorescence
response. For example, one concern is that because
ThT exists in micelles at the concentrations used to
monitor amyloid fibrils ( 5–20 lm) [41,47], and the
added compounds that modulate fibril formation are
often hydrophobic (a property which helps direct them
towards the inherently hydrophobic amyloid core),
they are likely to incorporate themselves into the ThT
micelles, which may affect the solution-state spectro-
scopic properties of the ThT [47]. Hence, the results
presented herein clearly highlight the need to investi-
gate for interference to ThT fluorescence when any
extrinsic compound is to be used in combination with
the ThT chromophore. This is, of course, particularly
relevant for conjugated aromatic molecules such as
polyphenols, which are typically spectroscopically
active in the ThT fluorescence range. Assessment
should first involve establishing any UV-visible absor-
bance and fluorescence properties of the exogenous
compound in the presence and absence of preformed
fibrils (at the intended ThT assay concentrations), to
ensure that there is no spectral activity in the regions
of 440 and 490 nm. Additional, nonspectroscopic-
based interference of ThT fluorescence should then be
investigated by adding the exogenous compound to
samples of preformed fibrils and ThT, and monitoring
for any changes in the ThT fluorescence emission
spectra over short time frames.
Herein, we also explored the use of the CR dye spec-
tral shift assay (absorbance at 540 nm) as a potential
alternative to the ThT fluorescence assays. It was
found that the absorptive contributions of the three
studied polyphenols could be accounted for via sub-
traction in this assay and therefore allowed the quanti-
fication of fibril formation (Fig. 4A). In using this
technique to assess the anti-amyloid activity of the
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polyphenols (Fig. 4B), it was shown that the polyphe-
nols are all poorly efficacious at preventing RCMj-CN
from forming b-sheet structures to which CR is capa-
ble of binding. Complementary TEM analysis indi-
cated that despite their weak ability to inhibit b-sheet
formation, the polyphenols dramatically alter the mor-
phology of RCMj-CN aggregation (Fig. 2). Their
presence yields a combination of stunted fibrillar and
prefibrillar RCMj-CN assemblies, indicating that they
may interfere with the monomer ⁄oligomer stacking
events that occur during fibril elongation [1,2]. It is
worth noting that the CR spectral shift approach
assumes that even if the added exogenous compound
affects fibril formation, its contribution to the CR
spectrum will remain unchanged. Furthermore, given
that the CR dye is also similarly aromatic in structure
to ThT [5], the potential for nonspectral interference
remains (even though we found no evidence of this in
our system). Therefore, in all circumstances where a
fibril-forming polypeptide is in the presence of an
added exogenous compound, complementary methods
should be used to assess fibril formation independently
of ThT fluorescence and CR spectrophotometric assays
(e.g. electron microscopy or atomic force microscopy
to visualize fibril morphology, X-ray fibre diffraction
to confirm cross-b-sheet structure, or even other opti-
cal techniques, such as using the mid-UV absorbance
of the peptide bond or intrinsic fluorescence of the
added compound) [7,48–50].
Experimental Procedures
Materials
Unless specified otherwise, all materials and reagents used
were of analytical grade and were obtained from the Sigma
Chemical Company (St Louis, MO, USA). Black lClear
96-microwell plates were supplied by Greiner Bio-One
(Stonehouse, UK) and Thin Seal self-adhesive plate covers
were purchased from Excel Scientific (Chicago, IL, USA).
Carbon-coated 400-mesh nickel TEM grids were purchased
from SPI Supplies (West Chester, PA, USA) and uranyl
acetate was bought from Agar Scientific (Stansted, UK).
j-Casein was reduced and carboxymethylated as described
by Shechter et al. [51], with minor modifications as per
Farrell et al. [52]. Lyophilized RCMj-CN was stored at
)20 C and all solutions of native RCMj-CN were pre-
pared in sodium phosphate buffer (50 mm, pH 7.4) at 4 C
immediately before use. The desired RCMj-CN concentra-
tion of 50 lm was achieved by standard spectrophotometric
methodology using a CARY 5000 UV-Vis-NIR spectropho-
tometer (Varian, CA, USA), a 1-cm path-length cuvette
and a molar extinction coefficient of 0.95 mLÆmg)1Æcm)1 at
280 nm [53]. Fibrillar RCMj-CN solutions (50 lm) were
prepared by pre-incubating native RCMj-CN solutions
(50 lm) at 37 C for 20 h to permit the formation of
mature amyloid fibrils [35,36]. Amyloid-b(1-42) was
purchased from AnaSpec Inc. (San Jose, CA, USA) and a
1-mg sample was reconstituted in 60 lL of ammonium
hydroxide buffer (1%), as directed by the manufacturer.
The reconstituted peptide was then diluted in sodium phos-
phate buffer (50 mm, pH 7.4) to 25 lm and incubated at
37 C for 4 h with vigorous shaking to induce the forma-
tion of mature amyloid-b(1-42) fibrils. After fibrillation, the
fibril solution was diluted to the desired concentration of
0.5 lm in glycine-NaOH buffer (50 mm, pH 8.5) to enhance
the ThT fluorescence induced by the dilute amyloid-b(1-42)
fibrils [23]. MilliQ water and all buffers were filtered using
a 0.2 lm syringe filter before use.
Preparation of samples for assay
The polyphenols, curcumin, quercetin and resveratrol, were
first solubilized in dimethylsulfoxide to stock concentrations
of 0.001, 0.01, 0.1, 0.5, 1, 3, 5 and 10 mm. To achieve the
desired molar ratio of polyphenol to native or fibrillar pro-
tein (as indicated in each figure), the polyphenol stocks were
added to protein solutions (prepared as described above)
such that the final concentration of dimethylsulfoxide was
1% (v ⁄ v) and the protein solution was not significantly
diluted. The residual concentration of dimethylsulfoxide was
confirmed to have no significant effect on fibrillation or
ThT ⁄CR binding (data not shown). Both quercetin and
curcumin are not soluble above 100 lm without using higher
concentrations of dimethylsulfoxide. Samples of polyphenol
alone were prepared by substituting the protein solution for
the same volume of sodium phosphate buffer. Where appro-
priate, ThT (5 or 10 lm) or CR (20 lm) was added to the
samples immediately before the assay from stock solutions
of ThT and CR (200 lm) prepared in the appropriate assay
buffer. It was established that a ratio of 20 lm CR to 50 lm
native and fibrillar samples of RCMj-CN resulted in the
most practicable and detectable change in CR absorbance at
540 nm as a result of the presence of fibrils (data not shown)
and these concentrations were therefore used in these
experiments.
In situ ThT fluorescence assay
Samples (200 lL) with ThT were incubated at 37 C in
black lClear 96-microwell plates that were sealed to
prevent evaporation. The ThT fluorescence intensity of
each sample was recorded every 5 min using a FLUOstar
OPTIMA plate reader (BMG Labtechnologies, Melbourne,
VIC, Australia) with 440 ⁄ 490-nm excitation ⁄ emission filters
set. As native RCMj-CN binds some ThT as a result of
its b-sheet content [52], the ThT data were normalized by
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plotting the change in ThT fluorescence (in arbitrary units,
a.u.), DF, as determined by the equation: DF = F–F30,
where F is the mean ThT fluorescence reading (in arbitrary
units, a.u.) from triplicate experiments and F30 is the
mean ThT fluorescence reading (in arbitrary units, a.u.)
after 30 min of incubation once all samples had evenly
equilibrated to 37 C. The presence of ThT at the con-
centration used did not affect RCMj-CN fibril formation
[35].
TEM
Aliquots (2 lL) were taken from samples of the in situ ThT
fluorescence assays, before or after the 1100 min incubation
period (as indicated in each figure), and were transferred
onto the surface of carbon-coated 400-mesh nickel TEM
grids. The grid surface was then washed with MilliQ water
passed through a 0.2-lm syringe filter (3 · 10 lL) and neg-
atively stained with 10 lL of uranyl acetate solution [2%
(w ⁄ v), in MilliQ water]. Between each wash, and after stain-
ing, excess solution was removed by blotting with filter
paper. The grid was left to air dry and was then viewed
under 25 000–64 000· magnification using a Philips CM100
Transmission Electron Microscope (Philips, Eindhoven, the
Netherlands) with an 80 kV excitation voltage.
Absorption and fluorescence emission spectra
UV-visible solution-state absorption spectra, or single-
wavelength absorbance of samples with and without ThT
or CR (as indicated in each figure), were recorded using a
CARY 5000 UV-Vis-NIR spectrophotometer and 0.2-cm
path-length cuvettes. Steady-state fluorescence emission
spectra of samples were acquired using a Cary Eclipse
fluorescence spectrophotometer (Varian, CA, USA) and a
0.2-cm path-length cuvette with the excitation and emis-
sion slit widths set at 10 and 20 nm, respectively. All
absorption and fluorescence spectra were recorded at room
temperature to prevent significant amyloid fibril formation
by RCMj-CN over the period of spectral acquisition. The
absorption spectrum of buffer was subtracted from all
sample absorption spectra. Fluorescence emission spectra
were corrected for minor contributions from scattered
excitation radiation by subtracting the spectrum of buffer
alone.
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